Ping Du, MD, PhD

Director
Takeda Development Center Americas, Inc.

Ping Du, MD, PhD, has over 20 years of experience in the areas of real-world epidemiologic study design, clinical outcomes research, and public health practice. She also received training in Preventive Medicine and infectious diseases. She had worked as a senior Research Scientist at the New York State Department of Health and as a faculty member at the Pennsylvania State University College of Medicine. Currently she is the Director of Global Evidence and Outcomes at Takeda, leading real-world studies in rare hematology.

Presentation(s):

PB0298 - A Systematic Review of the Current Epidemiology of Immune-Mediated and Congenital Thrombotic Thrombocytopenic Purpura caused by Severe ADAMTS13 Deficiencies
Sunday, July 10, 2022
6:30 PM – 7:30 PM
PB0824 - Characteristics and Clinical Burden Among Patients With von Willebrand Disease Eligible for Prophylaxis: Results From a Retrospective US Cohort Study
Monday, July 11, 2022
6:30 PM – 7:30 PM
PB0825 - Burden of Illness in Patients With von Willebrand Disease Receiving Prophylaxis Versus Potential Prophylaxis-Eligible Patients: A Post-Hoc Analysis of A European Socioeconomic Study
Monday, July 11, 2022
6:30 PM – 7:30 PM
PB0826 - A Systematic Review of Acquired von Willebrand Syndrome Associated With Cardiac Disorders: Epidemiology, Disease Burden, and Management
Monday, July 11, 2022
6:30 PM – 7:30 PM
PB0827 - A Systematic Review of Acquired von Willebrand Syndrome Associated With Non-Cardiac Diseases: Epidemiology, Disease Burden, and Management
Monday, July 11, 2022
6:30 PM – 7:30 PM